Merck (MRK) Gains from Investment Securities (2009 - 2016)

Merck (MRK) has reported Gains from Investment Securities for 8 consecutive years, with $4.0 million the latest figure, recorded in Q4 2016.

• In Q4 2016, Gains from Investment Securities fell 89.47% year-over-year to $4.0 million; the TTM figure through Dec 2016 stood at $16.0 million (down 68.0% YoY), while the FY2017 annual figure was $2.0 million, down 87.5% from the prior year.
• Gains from Investment Securities retreated to $4.0 million in Q4 2016 per MRK's latest filing, from $5.0 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $110.0 million in Q4 2012 and bottomed at $3.0 million in Q1 2015.
• Historically, Gains from Investment Securities has averaged $38.9 million across 5 years, with a median of $45.5 million in 2014.
• Annual changes were most pronounced in 2014 — Gains from Investment Securities jumped 1220.0% — and 2015, when it slumped 95.45%.
• Merck's Gains from Investment Securities stood at $110.0 million in 2012, then slumped by 46.36% to $59.0 million in 2013, then fell by 10.17% to $53.0 million in 2014, then decreased by 28.3% to $38.0 million in 2015, then tumbled by 89.47% to $4.0 million in 2016.
• Business Quant data shows MRK's Gains from Investment Securities at $4.0 million in Q4 2016, $5.0 million in Q3 2016, and $3.0 million in Q2 2016.